About
Basys.ai, founded in 2021 in Cambridge, Massachusetts, provides an AI engine for healthcare prior authorization that combines generative AI and deep learning to automate up to 90% of drug and medical procedure authorization requests with high accuracy, reducing integration time from up to one year to just weeks.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2023-08Seed$2M
Investors · Two Lanterns Venture Partners, Eli Lilly, Asset Management Ventures, Nina Capital, Chaac Ventures, Mayo ClinicSource · SVTR Weekly #014
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Basys.ai
AI automation of prior authorization requests for drugs and medical procedures
Seed · $2M · 2023-08
$2M
United States
BusinessLatest roundTotal raisedDate- Taxo
AI platform automating healthcare administrative tasks such as prior authorization and medical billing
Seed · $5M · 2025-03
$5M - Log10
AI platform that auto-generates clinical and regulatory submission documents for pharma companies, medical device makers and CROs
Seed · $7M · 2024-04
$7M - Planbase
Staff management automation platform for outpatient medical practices
Seed · $2M · 2025-11
$2M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Datamonk
Automates medical imaging data migration for hospitals (Agentic AI)
Pre-Seed · $2M · 2025-10
$2M - Rivercell
In-house automated wet lab generating large-scale single-cell perturbation data to train "AI virtual cell" models that predict human cell responses to drugs and genetic changes
Seed · 2026-10
— - Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes
Series B · $160M · 2026-09
$160M
Other / unspecified
BusinessLatest roundTotal raisedDate- Daffodil Health
Uses AI to automate healthcare pricing and administrative tasks, lowering costs for providers
Seed · $5M · 2024-05
$5M - FertilAI
EHR-integrated AI recommendations for fertility procedures, including ovulation tracking, IUI and IVF
Seed · $5M · 2024-11
$5M - OutPost Bio
Automated wet lab + machine learning to generate human microbiome data and predict microbial effects of drugs/products
Pre-Seed · $7M · 2026-03
$7M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 19 at a nearby stage · 36 in United States
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 31 in United States
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 11 at a nearby stage · 22 in United States
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 7 at a nearby stage · 20 in United States
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in United States
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 5 at a nearby stage · 15 in United States
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.